Contact
Contact
Press, research collaboration, programme updates, and financing enquiries each have a clear route below. For company identity, see About.
Press and general enquiries. Please do not send personal health information, clinical records, or patient-identifiable data by email. This is not a diagnosis service, crisis line, or trial enrolment portal.
Programme updates
Dated notes are on the Updates hub. For questions about programme news, email us with the subject line below (news only — not an investment waitlist).
Email · Programme updatesOnline form is not available on this site yet. Nothing has been sent from this page.
Research collaboration
Scientific or partnership enquiries: please state your institution and the nature of the enquiry.
Email · Research collaborationExplore a research collaboration — review public information, build an agenda and prepare a brief first.
Press
For journalists and media. Put “Press” in the subject. We aim to respond carefully rather than instantly.
Email · PressFinancing enquiries
Enquiry only — not an invest, subscribe, or pay path. Emailing does not confer eligibility, allocation, liquidity, or any investment right. See the FAQ.
We are evaluating a platform-supported route for eligible investors to help finance the CHR-P research programme, including a permissioned digital record of participation at closing where that proves feasible. If a platform path cannot meet legal, operational or investor-access requirements, a conventional private placement with a legal investor register remains the fallback. These are development objectives, not live offering terms. Neither path is available on this website: production investment, payment and token issuance remain inactive. Community updates and discussion are separate from any regulated investment process.
Email · Financing enquiryYou cannot invest, pay, or connect a wallet on our website.
Online form is not available on this site yet. Nothing has been sent from this page.
Privacy. Email is processed for enquiry handling only. Prefer organisational contact details where possible.
Available now
- Programme information, Scenario explorer, and Updates articles
- The four enquiry routes on this page
Being developed Not live
- Platform-supported financing path and permissioned digital unit — under evaluation; not live on this site
- No eligibility, allocation, or liquidity on this website
Follow programme updates
Read dated programme notes on the Updates hub, or use Programme updates on this page.